Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells

Molecular and Cellular Neuroscience

Volumn 25, Issue 1, 2004, Pages 111-123

  Nielsen, Joseph A ^a,b   Berndt, Jo Ann ^b   Hudson, Lynn D ^b   Armstrong, Regina C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MITOGENIC AGENT; MYELIN TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALIA;

EID: 1242284406     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.10.001     Document Type: Article

References (37)

1. Armstrong R.C. Isolation and characterization of immature oligodendrocyte lineage cells. Methods. 16:1998;282-292.
2. Armstrong R.C., Harvath L., Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27:1990;400-407.
3. Armstrong R.C., Kim J.G., Hudson L.D. Expression of myelin transcription factor I (MyTI), a "zinc-finger" DNA-binding protein, in developing oligodendrocytes. Glia. 14:1995;303-321.
4. Armstrong R.C., Migneault A., Shegog M.L., Kim J.G., Hudson L.D., Hessler R.B. High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein. J. Neuropathol. Exp. Neurol. 56:1997;772-781.
5. Baas D., Fressinaud C., Ittel M.E., Reeber A., Dalencon D., Puymirat J., Sarlieve L.L. Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3′-triiodo-L-thyronine. Neurosci. Lett. 176:1994;47-51.
6. Bansal R., Pfeiffer S.E. Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 anti- galactocerebroside. J. Neurosci. Res. 32:1992;309-316.
7. Behar T.N. Analysis of fractal dimension of O2A glial cells differentiating in vitro. Methods. 24:2001;331-339.
8. Belachew S., Chittajallu R., Aguirre A.A., Yuan X., Kirby M., Anderson S., Gallo V. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J. Cell Biol. 161:2003;169-186.
9. Bellefroid E.J., Bourguignon C., Hollemann T., Ma Q., Anderson D.J., Kintner C., Pieler T. X-MyT1, a Xenopus C2HC-type zinc finger protein with a regulatory function in neuronal differentiation. Cell. 87:1996;1191-1202.
10. Berndt J.A., Kim J.G., Tosic M., Kim C., Hudson L.D. The transcriptional regulator Yin Yang 1 activates the myelin PLP gene. J. Neurochem. 77:2001;935-942.
11. Billon N., Tokumoto Y., Forrest D., Raff M. Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev. Biol. 235:2001;110-120.
12. Breitschopf H., Suchanek G., Gould R.M., Colman D.R., Lassmann H. In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol. (Berl.). 84:1992;581-587.
13. Chandross K.J., Cohen R.I., Paras P. Jr., Gravel M., Braun P.E., Hudson L.D. Identification and characterization of early glial progenitors using a transgenic selection strategy. J. Neurosci. 19:1999;759-774.
14. Chen Z.F., Paquette A.J., Anderson D.J. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat. Genet. 20:1998;136-142.
15. Dubois-Dalcq M., Armstrong R.C. The oligodendrocyte lineage during myelination and remyelination. Martenson R.E. Myelin: Biology and Chemistry. 1992;81-122 CRC Press, Boca Raton.
16. Eccleston P.A., Silberberg D.H. The differentiation of oligodendrocytes in a serum-free hormone-supplemented medium. Brain Res. 318:1984;1-9.
17. Edlund T., Jessell T.M. Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell. 96:1999;211-224.
18. Eisenbarth G.S., Walsh F.S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4913-4917.
19. Gravel M., Di Polo A., Valera P.B., Braun P.E. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J. Neurosci. Res. 53:1998;393-404.
20. Hildesheim J., Kuhn U., Yee C.L., Foster R.A., Yancey K.B., Vogel J.C. The hSkn-1a POU transcription factor enhances epidermal stratification by promoting keratinocyte proliferation. J. Cell. Sci. 114:2001;1913-1923.
21. Hudson L.D. Control of gene expression by oligodendrocytes. Jesson K.R., Richardson W.D. Glial Cell Development: Basic Principles and Clinical Relevance. 2001;209-221 Oxford Univ. Press.
22. Hudson L.D., Berndt J.A., Puckett C., Kozak C.A., Lazzarini R.A. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Natl. Acad. Sci. U. S. A. 84:1987;1454-1458.
23. Kim J.G., Hudson L.D. Novel member of the zinc finger superfamily: a C2-HC finger that recognizes a glia-specific gene. Mol. Cell. Biol. 12:1992;5632-5639.
24. Kim J.G., Armstrong R.C., v Agoston D., Robinsky A., Wiese C., Nagle J., Hudson L.D. Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system. J. Neurosci. Res. 50:1997;272-290.
25. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24:2001;39-47.
26. Louis J.C., Muir D., Varon S. Autocrine inhibition of mitotic activity in cultured oligodendrocyte-type-2 astrocyte (O-2A) precursor cells. Glia. 6:1992;30-38.
27. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., Rowitch D.H. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell. 109:2002;75-86.
28. Matsushita F., Kameyama T., Marunouchi T. NZF-2b is a novel predominant form of mouse NZF-2/MyT1, expressed in differentiated neurons especially at higher levels in newly generated ones. Mech. Dev. 118:2002;209-213.
29. O'Neill E.M., Ellis M.C., Rubin G.M., Tjian R. Functional domain analysis of glass, a zinc-finger-containing transcription factor in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6557-6561.
30. Raff M.C., Miller R.H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 303:1983;390-396.
31. Redwine J.M., Armstrong R.C. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J. Neurobiol. 37:1998;413-428.
32. Rogister B., Ben-Hur T., Dubois-Dalcq M. From neural stem cells to myelinating oligodendrocytes. Mol. Cell. Neurosci. 14:1999;287-300.
33. Romm E., Kim J.G., Kim N.W., Nagle J., L.D. H. The Myt1 family recruits histone deacetylase to regulate neural transcription. J. Neurochem. Abstr. 81(Suppl. 1):2002;5.
34. Simpson P.B., Armstrong R.C. Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration. Glia. 26:1999;22-35.
35. Sommer I., Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83:1981;311-327.
36. Wang S., Sdrulla A., Johnson J.E., Yokota Y., Barres B.A. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron. 29:2001;603-614.
37. Wrathall J.R., Li W., Hudson L.D. Myelin gene expression after experimental contusive spinal cord injury. J. Neurosci. 18:1998;8780-8793.